Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 25, 2023 | Developing and Validating Robust Cell-Based Assays for GMP QC Testing, Upcoming Webinar Hosted by Xtalks | The use of cell-based assays has the potential to revolutionize growing therapeutic areas, allowing for the development of more targeted and effective drugs. TORONTO (PRWEB) May 25, 2023 Cell-based assays in developing cutting-edge therapeu... |
| Mar 20, 2023 | Next-Generation Complement Therapeutics — Exploring Challenges and Solutions from Bench to Bedside, Upcoming Webinar Hosted by Xtalks | The rise in the number of conditions linked to dysregulation of the complement system clearly underscores the potential of complement-modulating therapeutics. TORONTO (PRWEB) March 20, 2023 Complement is an important and integral part of th... |
Reviews 0
FAQ about Svar Life Science AB
When was Svar Life Science AB founded?
Svar Life Science AB was founded in 1992.
What has the press written about Svar Life Science AB?
Parsers VC has collected 3 articles mentioning Svar Life Science AB, among them “Developing and Validating Robust Cell-Based Assays for GMP QC Testing, Upcoming Webinar Hosted by Xtalks” (May 25, 2023) and “Next-Generation Complement Therapeutics — Exploring Challenges and Solutions from Bench to Bedside, Upcoming Webinar Hosted by Xtalks” (Mar 20, 2023).
Is Svar Life Science AB still active?
Yes, Svar Life Science AB is active; its latest activity on Parsers VC dates from Jun 8, 2023.